;

Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld

  • Publish date: Thursday، 22 December 2022
Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld

Abu Dhabi has received the first global shipment of AstraZeneca’s COVID-19 long-acting antibody medication, Evusheld, after gaining emergency use authorisation from the UAE’s Ministry of Health and Prevention.

Evusheld, is designed to prevent severe infection and death amongst immunocompromised patients.

The first doses of Evusheld arrived in Abu Dhabi on Monday following a collaboration of key partners including Rafed, the UAE’s Primary Group Purchasing Organisation, along with Etihad Cargo, AstraZeneca and Abu Dhabi Airports Company.

The breakthrough medication will be stored at Rafed’s distribution centre to be transported to various destinations.

This article was previously published on UAE Moments.To see the original article, click here

Follow us on our Whatsapp channel for latest news